Zhongkechu Peptide Linyi BiotechTirzepatide
Ordered Tirzepatide from Zhongkechu Peptide Linyi Biotech? Mail in a sample (US only) and let us test it.
Test my supplyRecent results drive the concern: after earlier 99.8–99.9% purity passes, two Nov 2 tests on Z51-Z12/Z51Z12 came back at 72.3% and 63.9% purity. That sharp late break is the key detail behind the weaker purity-focus score.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Zhongkechu Peptide Linyi Biotech rows.
Cancel anytime
About Zhongkechu Peptide Linyi Biotech test results from Finnrick
Zhongkechu Peptide Linyi Biotech is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 5 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Zhongkechu Peptide Linyi Biotech peptides in this dataset are Tirzepatide (5 tests), PT-141 (0 tests) and Tesamorelin (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 5 recent tests.
Ordered Tirzepatide from Zhongkechu Peptide Linyi Biotech? Mail in a sample (US only) and let us test it.
Test my supply